Literature DB >> 4993220

Australia (hepatitis-associated) antigen: physicochemical and immunological characteristics.

G L Le Bouvier, R W McCollum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4993220      PMCID： PMC7131679          DOI： 10.1016/s0065-3527(08)60027-5

Source DB:  PubMed          Journal:  Adv Virus Res        ISSN： 0065-3527            Impact factor:   9.937


× No keyword cloud information.
  67 in total

1.  An isoprecipitation reaction distinguishing human serum-protein types.

Authors:  A C ALLISON; B S BLUMBERG
Journal:  Lancet       Date:  1961-03-25       Impact factor: 79.321

2.  Australia antigen and acute viral hepatitis.

Authors:  W T London; A I Sutnick; B S Blumberg
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

3.  Additional specificities of Australia antigen and the possible identification of hepatitis carriers.

Authors:  C Levene; B S Blumberg
Journal:  Nature       Date:  1969-01-11       Impact factor: 49.962

4.  Particles associated with Australia antigen in the sera of patients with leukaemia, Down's Syndrome and hepatitis.

Authors:  M E Bayer; B S Blumberg; B Werner
Journal:  Nature       Date:  1968-06-15       Impact factor: 49.962

5.  Association between lepromatous leprosy and Australia antigen.

Authors:  B S Blumberg; L Melartin; M Lechat; R S Guinto
Journal:  Lancet       Date:  1967-07-22       Impact factor: 79.321

6.  Hepatitis antigen. Correlation with disease and infectivity of blood-donors.

Authors:  D J Gocke; N B Kavey
Journal:  Lancet       Date:  1969-05-31       Impact factor: 79.321

7.  S.H. antigen in haemodialysis-associated hepatitis.

Authors:  G C Turner; G B White
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

8.  Hepatitis-associated antigen in chronic liver disease.

Authors:  V Reinicke; E Nordenfelt
Journal:  Lancet       Date:  1970-01-17       Impact factor: 79.321

9.  Family studies of a human serum isoantigen system (Australia antigen).

Authors:  B S Blumberg; L Melartin; R A Guint; B Werner
Journal:  Am J Hum Genet       Date:  1966-11       Impact factor: 11.025

10.  Australia antigen in chronic hepatitis in Australia.

Authors:  J D Mathews; I R Mackay
Journal:  Br Med J       Date:  1970-01-31
View more
  8 in total

1.  Essential malignant hypertension with renal failure and persistent Australia-antigenaemia.

Authors: 
Journal:  Br Med J       Date:  1973-01-27

2.  Electron microscopic observations and speculations on Australia antigen.

Authors:  J D Almeida
Journal:  Postgrad Med J       Date:  1971-07       Impact factor: 2.401

3.  Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw.

Authors:  R Chairez; F B Hollinger; J P Brunschwig; G R Dreesman
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

4.  T-lymphocytes and hepatitis B serology.

Authors:  E Kaklamani; D Trichopoulos; G Papaevangelou; M Drouga; D Karalis; G Papoutsakis
Journal:  Infection       Date:  1978       Impact factor: 3.553

5.  Seroepidemiological study of HBV infections in Athens, Greece.

Authors:  G Papaevangelou; A Kyriakidou; C Vissoulis; D Trichopoulos
Journal:  J Hyg (Lond)       Date:  1976-04

6.  Biophysical and biochemical heterogeneity of purified hepatitis B antigen.

Authors:  G R Dreesman; F B Hollinger; J R Suriano; R S Fujioka; J P Brunschwig; J L Melnick
Journal:  J Virol       Date:  1972-09       Impact factor: 5.103

7.  Production of potent anti-Australia antigen sera of high specificity and sensitivity in goats.

Authors:  G R Dreesman; F B Hollinger; R M McCombs; J L Melnick
Journal:  Infect Immun       Date:  1972-02       Impact factor: 3.441

8.  Hepatitis B surface antigen: regional variation in sub-type ratio in the Canadian Red Cross donor population.

Authors:  J P Valet; J Matte; A P O'Connell; J Duravetz
Journal:  Can Med Assoc J       Date:  1975-05-17       Impact factor: 8.262
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.